Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations
Status:
Completed
Trial end date:
2005-05-04
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. Postmenopausal women with moderate to severe hot flashes
have been recruited into the trial. The earliest effect of ultra low dose HRT (hormone
replacement therapy) on frequency and severity of menopausal symptoms, bleeding patterns and
safety of different hormonal combinations will be evaluated and compared to placebo over the
six month treatment period.